DETECTION OF MINIMAL RESIDUAL DISEASE
微小残留疾病的检测
基本信息
- 批准号:3771401
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:acute leukemia acute lymphocytic leukemia biomarker bone marrow transplantation chronic myelogenous leukemia diagnosis design /evaluation human morbidity human subject human therapy evaluation immunocytochemistry in situ hybridization messenger RNA myelogenous leukemia neoplasm /cancer diagnosis neoplasm /cancer genetics neoplasm /cancer relapse /recurrence neoplasm /cancer remission /regression nucleic acid sequence polymerase chain reaction restriction fragment length polymorphism southern blotting tissue donors tissue mosaicism
项目摘要
The broad, long-term objectives of this program are:
The development of diagnostic tests for the detection of minimal residual
disease.
The incorporation of such tests into protocols that improve patient
survival after bone marrow transplantation.
The specific aims of this project are:
1) Determine whether the polymerase chain reaction (PCR) can detect minimal
residual disease in patients transplanted for CML.
2) Identify which cells give rise to PCR positivity in remission CML
patients.
3) Determine the utility of PCR to detect minimal residual disease in
patients with ALL.
Patients will be evaluated by PCR prior to BMT and at defined intervals
after BMT
Existing PCR methods for detection of BCR-abl mRNA rearrangements will be
applied to patients with Philadelphia (Ph) positive CML and ALL. Patient
specific immunoglobulin markers will be used for PCR studies of the Ph-
negative ALL patients.
Many posttransplant patients will relapse. Conventional technologies can
not distinguish who is truly cured and who will relapse. Studies outlined
in this project should allow for the identification of these two patient
populations and lay the foundation for early intervention that may
ultimately lead to increased overall transplant survival.
该计划的广泛和长期目标是:
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
E DONNALL THOMAS其他文献
E DONNALL THOMAS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('E DONNALL THOMAS', 18)}}的其他基金
ALLOGENEIC MARROW GRAFTING FOR TREATMENT OF ACUTE LEUKEMIA
同种异体骨髓移植治疗急性白血病
- 批准号:
3771396 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Understanding of the onset and recurrence pattern of intractable acute lymphocytic leukemia based on clone analysis
基于克隆分析了解难治性急性淋巴细胞白血病的发病和复发模式
- 批准号:
20K08723 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Novel Inhibitors of Multi-Drug-Resistant Mutants of BCR-ABL for the Treatment of Chronic Myelogenous Leukemia (CML) and Ph Positive Acute Lymphocytic Leukemia (ALL).
BCR-ABL 多重耐药突变体的新型抑制剂,用于治疗慢性粒细胞白血病 (CML) 和 Ph 阳性急性淋巴细胞白血病 (ALL)。
- 批准号:
9047400 - 财政年份:2015
- 资助金额:
-- - 项目类别:
The Role of Genetic Variants in Sensitivity to Methotrexate in Acute Lymphocytic Leukemia Survivors
遗传变异在急性淋巴细胞白血病幸存者对甲氨蝶呤敏感性中的作用
- 批准号:
319114 - 财政年份:2014
- 资助金额:
-- - 项目类别:
Fellowship Programs
Targeting the Bone Marrow Microenvironment In Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的骨髓微环境
- 批准号:
8595788 - 财政年份:2013
- 资助金额:
-- - 项目类别:
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的缺氧微环境
- 批准号:
8023518 - 财政年份:2011
- 资助金额:
-- - 项目类别:
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的缺氧微环境
- 批准号:
8404025 - 财政年份:2011
- 资助金额:
-- - 项目类别:
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的缺氧微环境
- 批准号:
8220724 - 财政年份:2011
- 资助金额:
-- - 项目类别:
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的缺氧微环境
- 批准号:
8599754 - 财政年份:2011
- 资助金额:
-- - 项目类别:
INSULIN RESISTANCE IN CHILDREN WITH ACUTE LYMPHOCYTIC LEUKEMIA UNDERGOING INDUCT
正在接受治疗的急性淋巴细胞白血病儿童的胰岛素抵抗
- 批准号:
8356701 - 财政年份:2010
- 资助金额:
-- - 项目类别:
INSULIN RESISTANCE IN CHILDREN WITH ACUTE LYMPHOCYTIC LEUKEMIA UNDERGOING INDUCT
正在接受治疗的急性淋巴细胞白血病儿童的胰岛素抵抗
- 批准号:
8166720 - 财政年份:2009
- 资助金额:
-- - 项目类别:














{{item.name}}会员




